ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Download in electronic PDF format for $75
Abstract: Hospice patients at the end stages of life often suffer nausea and vomiting, distressing symptoms that are either side effects of medications or direct effects of the underlying disease state. Such symptoms can greatly diminish the hospice patient’s quality of life. Effective pharmacotherapy is available, but in many cases traditional dosage forms are incompatible with the patient’s physical condition, cause discomfort, or are difficult for family members to administer. In such cases, a compounded preparation containing lorazepam, diphenhydramine, haloperidol, and metoclopramide—commonly referred to as ABHR gel—has proven highly effective. A number of case reports are presented to illustrate the effectiveness of ABHR gel in relieving the symptoms of nausea and vomiting in hospice patients. Also discussed are the causes of vomiting and the mechanisms of each of the medications contained in the ABHR gel.
Related Keywords:
hospice, palliative care, palliation, symptoms, nausea, vomiting, antiemetics, ABHR gel, lorazepam, diphenhydramine, haloperidol, metoclopramide, transdermal administration, topical preparation, combination therapy
Related Categories:
GASTROENTEROLOGY, HOSPICE/PALLIATIVE CARE, MENTAL HEALTH, CASE REPORTS, DOSAGE FORMS/DRUG CARRIERS
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Moon Richard B
|
Mar/Apr 2006
Pg. 95-98
|
Nausea and Vomiting in Hospice Patients
Boomsma Diane
|
Jul/Aug 2000
Pg. 250-251
|
Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel
Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
|
Mar/Apr 2020
Pg. 168-175
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Hospice Symptom Relief Kit: An Update
Petrin Ronald L
|
Jul/Aug 2006
Pg. 288-290
|
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis
Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
|
Mar/Apr 2006
Pg. 147-153
|
ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl)
Allen Loyd V Jr
|
May/Jun 2003
Pg. 183
|
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Zur Eyal
|
Mar/Apr 2013
Pg. 113-123
|
Hospice from a Compounding Pharmacist's Perspective
Jones Marty
|
Mar/Apr 2006
Pg. 89-93
|
Hospice and Compounding Pharmacy: Once Inseperable
Williams LaVonn A
|
Jan/Feb 2008
Pg. 28-37
|
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Muller George
|
May/Jun 2009
Pg. 220-221
|
The Symptom Relief Kit for Hospice Patients
Petrin Ronald L
|
Mar/Apr 1998
Pg. 116-117
|
Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site
Wood Robert M
|
Jul/Aug 2024
Pg. 278-281
|
Custom-Making Medications for the Hospice Patient
Horwitz Robert
|
Jul/Aug 2000
Pg. 255-256
|
Dexamethasone 1.2%, Lorazepam 0.1%, Haloperidol 0.1%, Diphenhydramine HCl 2.4% and Metoclopramide HCl 2.4% in PLO
Allen Loyd V Jr
|
Jul/Aug 2000
Pg. 297
|
Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion
Allen Loyd V Jr
|
Nov/Dec 2011
Pg. 504
|
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
|
May/Jun 2013
Pg. 247-253
|
Ketamine for Pain in Hospice Patients
Wood Robert M
|
Jul/Aug 2000
Pg. 253-254
|
Hospice and the Role of the Compounding Pharmacist
Carling Maureen A
|
Jul/Aug 2000
Pg. 246-249
|
Return to Top |